The Importance of Insulin Administration in the Critical Care Unit

Advances in Surgery

Volumn 40, Issue , 2006, Pages 47-57

  Lipsett, Pamela A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ANIMAL; CORONARY ARTERY BYPASS GRAFT; CRITICAL ILLNESS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ESOPHAGUS DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; METABOLISM; PATHOPHYSIOLOGY; REVIEW; SEPSIS; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD GLUCOSE; CORONARY ARTERY BYPASS; CRITICAL ILLNESS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; ESOPHAGEAL DISEASES; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; LENGTH OF STAY; SEPSIS;

EID: 33750459729     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2006.05.003     Document Type: Review

References (51)

1. Fink M.P. Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 17 (2001) 219-237
2. Brealey D., Brand M., Hargreaves I., et al. Association between in mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 (2002) 219-223
3. Bernard C. Leçons sur les phénomènes de la vie communs aux animaux et aux végétaux, vol. 1. Paris: J.B.Baillière et Fils 1878.
4. Van den Berghe G. How does blood glucose control saves lives in intensive care. J Clin Invest 114 (2004) (1187-95)
5. Bochicchio G., Sing J., Joshi M., et al. Persistent hyperglycemia is predictive of outcome in critically ill in trauma. J Trauma 58 (2005) 921-925
6. Umpierrez G.E., Isaacs S.D., Bazargan N., et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87 (2002) 978-982
7. Wolfe R.R., Herndon D.N., Jahoor F., et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 317 (1987) 403-408
8. Wolfe R.R., Allsop J.R., and Burke J.F. Glucose metabolism in man: responses to intravenous glucose infusion. Metabolism 28 (1979) 210-220
9. Mizock B.A. Alterations in carbohydrates metabolism during stress: a review of the literature. Am J Med 98 (1995) 75-84
10. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI): effect on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
11. Capes S., Hunt D., Malmberg K., et al. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systemic overview. Lancet 355 (2000) 773-778
12. Yudkin J.S., and Oswald G.A. Hyperglycemia, diabetes, and myocardial infarction. Diabet Med 4 (1987) 13-18
13. Kagansky N., Levy S., and Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol 58 (2001) 1209-1212
14. Estrada C.A., Young J.A., Nifong L.W., et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 75 (2003) 1392-1399
15. Latham R., Lancaster A.D., Covington J.F., et al. The association of diabetes and glucose control with surgical infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 22 (2001) 607-612
16. Ljungqvist O., Nygren J., and Thorel A. Insulin resistance and elective surgery. Surgery 128 (2000) 757-760
17. Das U. Insulin: an endogenous cardioprotector. Curr Opin Crit Care 9 (2003) 375-383
18. Mohan I.K., and Das U.N. Oxidant stress, anti-oxidants and nitric oxide in non-insulin dependent diabetes mellitus. Med Sci Res 25 (1997) 55-57
19. Das U.N., Kumar K.V., and Mohan I.K. Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy. J Nutr Med 4 (1994) 149-155
20. Nishikawa T., Edelstein D., Du X.L., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404 (2000) 787-790
21. Mohanty P., Hamouda W., Garg R., et al. Glucose challenge stimulates reactive oxygen species (ROS) generation by leukocytes. J Clin Endocrinol Metab 85 (2000) 2970-2974
22. Das U.N. Nutritional factors in the pathobiology of human essential hypertension. Nutrition 17 (2001) 337-346
23. Booth G., Stalker T.J., Lefer A.M., et al. Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol 280 (2001) E848-E856
24. Esposito K., Nappo F., Marfella R., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106 (2002) 2067-2072
25. Srinivasan S., Yeh M., Danziger E.C., et al. Glucose regulates monocytes adhesion through endothelial production of interleukins-8. Circ Res 92 (2003) 371-377
26. Fogh K., Larsen C.G., Iversen L., et al. Interleukin-8 stimulates the formation of 15-hydroxyeicosatetraenoic acid by human neutrophils in vitro. Agents Actions 35 (1992) 227-231
27. Satomi N., Sakurai A., and Haranaka K. Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophages. J Natl Cancer Inst 74 (1985) 1255-1260
28. Lazar H.L., Chipkin S.R., Fitzgerald C.A., et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 30 109 (2004) 1497-1502
29. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
30. Fath-Ordoubadi F., and Beatt K.J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 96 (1997) 1152-1156
31. Natali A., L'Abbate A., and Ferrannini E. Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality. Eur Heart J 24 (2003) 639-648
32. Davi G., Catalan I., and Averna M. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 322 (1990) 1769-1774
33. Rao V., Christakis G.T., Weisel R.D., et al., for the ICT investigators. The Insulin Cardioplegia Trial: myocardial protection for urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 123 (2002) 928-935
34. Vriesendorp T.M., Morelis Q.J., Devries J.H., et al. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endovasc Surg 28 (2004) 520-525
35. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
36. Vriesendorp T.M., DeVries J.H., Hulscher J.B., et al. Early postoperative hyperglycaemia is not a risk factor for infectious complications and prolonged in-hospital stay in patients undergoing oesophagectomy: a retrospective analysis of a prospective trial. Crit Care 8 (2004) R437-R442
37. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systemic overview. Stroke 32 (2001) 2426-2432
38. Rovlias A., and Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 46 (2000) 335-342
39. Scott J.F., Robinson G.M., French J.M., et al. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the glucose insulin in stroke trial (GIST). Stroke 30 (1999) 793-799
40. Zerr K.J., Furnary A.P., Grunkemeier G.L., et al. Glucose control lowers the risk of wound infection in diabetics after open heart operation. Ann Thorac Surg 63 (1997) 356-361
41. Furnary A.P., Zerr K.J., Grunkemeier G.L., et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67 (1999) 352-360
42. Goodson W.H., and Hung T.K. Studies of wound healing in experimental diabetes mellitus. J Surg Res 22 (1977) 221-227
43. Rosenberg C.S. Wound healing in the patient with diabetes mellitus. Nurs Clin North Am 25 (1990) 247-261
44. Weringer E.J., and Arquilla E.R. Wound healing in normal and diabetic Chinese hamsters. Diabetologia 21 (1981) 394-401
45. Krinsley J., and Grissler B. Intensive glycemic management in critically ill patients. Jt Comm J Qual Patient Saf 31 (2005) 308-312
46. Van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31 (2003) 359-366
47. Vanhorebeek I., De Vos R., Mesotten D., et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365 (2005) 53-59
48. Mesotten D., Swinnen J.V., Vanderhoydonc F., et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 89 1 (2004) 219-226
49. Hansen T.K., Thiel S., Wouters P.J., et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88 3 (2003) 1082-1088
50. Langouche L., Vanhorebeek I., Vlasselaers D., et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115 8 (2005) 2277-2286
51. Vanhorebeek I., Langouche L., and Van den Berghe G. Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness?. Curr Opin Crit Care 11 4 (2005) 304-311